PULMONARY TUBERCULOSIS
Clinical trials for PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 9-Month pill regimen could transform Drug-Resistant TB care
Disease control Not yet recruitingThis study tests a 9-month, all-oral drug combination (BLMZ) for people with rifampicin-resistant tuberculosis. About 120 participants aged 12 and older will take the pills and be monitored for 24 months. The goal is to see if this shorter treatment works well and is safe for Chi…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated May 26, 2026 05:57 UTC
-
AI-Designed TB treatment could boost cure rates and cut side effects
Disease control Not yet recruitingThis study tests a new two-drug combination for tuberculosis (TB) designed by artificial intelligence. The goal is to see if it works better and causes fewer liver problems than the standard four-drug regimen. About 200 adults with newly diagnosed, drug-sensitive TB will take eit…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Ministry of Health, Saudi Arabia • Aim: Disease control
Last updated May 18, 2026 12:10 UTC